Dr Yiping Chen
Senior Research Fellow
Yiping Chen is a senior research fellow at the CTSU, University of Oxford. She qualified in clinical medicine in 1985 at Shanghai Medical University (now Fudan University) and then worked as junior neurologist in University affiliated teaching hospital, Hua-shan hospital in Shanghai. In 1988 she was awarded Sino-British Friendship Scholarship to study in the UK and gained her PhD at the University of Oxford in 1993.
She joined CTSU in 1998 and has worked as study coordinator and senior research fellow in several CTSU-led large clinical trials such as COMMIT/CCS2, SHARP, HPS2-THRIVE, REVEAL. During 2006-2016 she also plays a leading role in running Oxford-China Fellowship programmes which provides residence training in epidemiology, medical statistics and clinical trials methodology for the clinical doctors, public health workers from China.
She is currently leading a multi-disciplinary team in the China Kadoorie Biobank (CKB) of 0.5 million people, responsible for developing strategies and procedures related to validation of electronically reported clinical events and for conducting disease validation and adjudication in collaboration with clinical specialists in China for CKB. Her main research interests are in the fields of clinical epidemiology of cardiovascular diseases, major depression, and sleeping disorders
Sleep duration and risk of stroke and coronary heart disease: a 9-year community-based prospective study of 0.5 million Chinese adults.
Chen Y. et al, (2023), BMC Neurol, 23
Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults.
Yao P. et al, (2023), Eur J Epidemiol
Genome-wide polygenic risk score, cardiometabolic risk factors, and type 2 diabetes mellitus in the Chinese population.
Huang N. et al, (2023), Obesity (Silver Spring)
Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.
Yao P. et al, (2023), Int J Epidemiol, 52, 1197 - 1208
Healthy lifestyle and life expectancy free of major chronic diseases at age 40 in China.
China Kadoorie Biobank Collaborative Group None., (2023), Nat Hum Behav